TABLE 1.
Demographics and characteristics of the analysis cohort.
| Characteristic, n (%) | Patients (N = 6271) |
|---|---|
| Age at diagnosis | |
| Age <70 years | 3103 (49) |
| Age ≥70 years | 3168 (51) |
| Sex | |
| Male | 3431 (55) |
| Female | 2840 (45) |
| Practice type where care received | |
| Community | 5619 (90) |
| Academic | 652 (10) |
| Year of diagnosis | |
| 2011 | 301 (4.8) |
| 2012 | 464 (7.4) |
| 2013 | 576 (9.2) |
| 2014 | 641 (10) |
| 2015 | 745 (12) |
| 2016 | 907 (14) |
| 2017 | 831 (13) |
| 2018 | 917 (15) |
| 2019 | 852 (14) |
| ISS stage at diagnosis | |
| I | 1249 (20) |
| II | 1172 (19) |
| III | 1293 (21) |
| Unknown/not documented | 2557 (41) |
| ECOG performance status at diagnosis | |
| 0 | 1145 (18) |
| 1 | 1250 (20) |
| 2+ | 675 (11) |
| Unknown/not documented | 3201 (51) |
| Stem cell transplant, yes | 1563 (25) |
| High‐riska cytogenetics, yes | 1840 (29) |
| Deceased | 2163 (34) |
Abbreviations: ECOG, Eastern Cooperative Oncology Group; ISS, International Staging System.
a
Based on cytogenetic abnormality: del(17/17p), t(4;14), t(14;16), t(14;20), gain(1q) [chromosome 1 abnormalities].